Variability of Impedance Pneumography Tidal Breathing Flow-volume Curves During Sleep in Healthy Children

May 28, 2018 updated by: Revenio Research
This is an observational study for the assessment of normal overnight variation in small healthy children using the Ventica Lung Function Testing System. The study is carried out to establish reference ranges for overnight lung function variation using the Ventica test, and to assess the impact of the demographic factors on the Ventica results.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zagreb, Croatia, 10000
        • Children's Hospital Srebrnjak

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

Young children screened to have small probability of asthma or wheezing

Description

Inclusion Criteria:

  • 18 months-6 years, both sexes
  • Healthy at the time of inclusion
  • Laboratory analyses in the reference range or not clinically relevant according to the investigator judgement
  • Lung function in the reference range with a negative bronchodilator test result
  • Signed informed consent

Exclusion Criteria:

  • Preterm birth
  • Chronic respiratory disorder of prematurity
  • Recurrent bronchitis or recurrent hospitalizations because of a respiratory illness (recurrent pneumonia)
  • Primary immunodeficiency
  • Chronic rhinosinusitis, synonasal polyposis
  • Nasal congestion, adenotonsillar hypertrophy, signs and symptoms of sleep apnea or sleep disordered breathing
  • Acute respiratory infection or hospitalization because of an acute illness within 4 weeks prior to inclusion
  • Personal or family history or clinical evidence of asthma, atopy or other chronic respiratory disorders (high risk for asthma and allergy)
  • Use of asthma rescue or maintenance medication within 4 weeks prior to inclusion
  • Implanted or external active medical devices such as pacemakers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Normal range of variables of tidal breathing flow-volume curves (CSRmin, NLmin, etc.)
Time Frame: 1-3 nights per subject
Analyse the normal range of variables that describe the shape and variability of tidal breathing flow-volume curves during natural night sleep obtained with impedance pneumography
1-3 nights per subject

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Davor Plavec, MD, PhD, Children's Hospital Srebrnjak

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 17, 2017

Primary Completion (Actual)

July 3, 2017

Study Completion (Actual)

July 3, 2017

Study Registration Dates

First Submitted

May 28, 2018

First Submitted That Met QC Criteria

May 28, 2018

First Posted (Actual)

June 11, 2018

Study Record Updates

Last Update Posted (Actual)

June 11, 2018

Last Update Submitted That Met QC Criteria

May 28, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • VCS-001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Subjects

3
Subscribe